Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ORIC
#1992
Oric Pharmaceuticals, Inc. Common Stock
13.450
0
+4.59%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+4.59%
Monatliche Änderung
+11.80%
6 month change
-0.44%
Jahresänderung
-0.44%
Vorheriger Schlusskurs
12.860
0
Open
13.450
0
Bid
Ask
Low
13.450
0
High
13.450
0
Volumen
173
Märkte
Aktien
Gesundheitswesen
ORIC
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
70.57 M
71.03 M
71.09 M
97.12 M
97.39 M
100.36 M
—
Valuation ratios
Enterprise value
679.08 M
513.78 M
347.34 M
909.93 M
1.12 B
775.26 M
3.15 B
Price to earnings ratio
-5.69
-4.41
-2.97
-5.34
-6.9
-5.56
-20.77
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
6.06
4.99
3.42
6.1
7.95
6.47
23.94
Price to book ratio
0.59
2.31
0.38
0.69
0.81
1.87
3.75
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.13
0.12
0.1
0.08
0.07
0.38
Return on equity %
0.13
0.15
0.14
0.11
0.08
0.08
0.41
Return on invested capital %
—
-604.51
—
—
—
-42.57
—
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
13.15
10.56
12
16.13
14.65
14.13
56.91
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.41
0.4
0.46
0.39
0.25
0.26
1.36
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.86
3.67
2.87
3.62
2.9
3.21
12.59
Net current asset value per share
3.96
3.76
2.98
3.73
2.99
3.29
12.98
Tangible book value per share
3.88
3.49
3.09
4.15
4.11
4.38
15.73
Working capital per share
3.66
3.4
2.73
3.5
2.78
3.05
12.06
Book value per share
3.88
3.49
3.09
4.15
4.11
4.38
15.73
Nachrichten
H.C. Wainwright hebt Kursziel für ORIC Pharmaceuticals nach Studienfortschritten an
H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress
Oppenheimer bestätigt Outperform-Rating für ORIC-Aktie mit Kursziel von $15
Oppenheimer reiterates Outperform on ORIC stock, $15 target
Oric Pharmaceuticals: Neues ATM-Programm über 200 Millionen US-Dollar aufgelegt
Oric Pharmaceuticals files new $200 million at-the-market offering prospectus
Oric Pharmaceuticals: Direktor Heyman verkauft Aktien im Wert von 80.430 $
Oric Pharmaceuticals director Heyman sells shares worth $80,430
ORIC: Transition To Late-Stage Development Presents Upside (NASDAQ:ORIC)
Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80
H.C. Wainwright bestätigt Kaufempfehlung für ORIC Pharmaceuticals vor ereignisreichem Jahr 2026
H.C. Wainwright reiterates Buy rating on ORIC Pharmaceuticals stock